Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0002023658-25-000015
Filing Date
2025-03-28
Accepted
2025-03-28 09:12:16
Documents
4
Effectiveness Date
2025-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 s-8coversheet.htm S-8 56469
2 EX-107 bicara-sx8ex107202531825.htm EX-FILING FEES 19580
3 EX-5.1 bicara-sx8ex51opinion2025.htm EX-5.1 7822
4 EX-23.1 a231kpmgconsents-8.htm EX-23.1 1688
  Complete submission text file 0002023658-25-000015.txt   86560
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Filer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286209 | Film No.: 25781786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)